市場調查報告書

全球免標定陣列系統市場:成長,趨勢,預測

Label-free Array Systems Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 850264
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球免標定陣列系統市場:成長,趨勢,預測 Label-free Array Systems Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球免標定陣列系統市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 促進要素
    • 超越認證檢測技術的優點
    • 製藥公司,生物科技企業的研究開發投資的擴大
    • 免標定技術的進步
  • 阻礙要素
    • 設備成本高
    • 認識不足
  • 波特五力分析

第5章 市場區隔

  • 各技術
    • 表面電漿子共振
    • 生物薄膜干涉技術
    • 細胞感應電光譜學
    • 其他
  • 各用途
    • 藥物研發
    • 蛋白質介面分析
    • 抗體特性化與開發
    • 蛋白質複合體與連鎖分析
    • 其他
  • 各終端用戶
    • CRO
    • 農業研究機關
    • 研究開發實驗室
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Agilent Technologies
    • Attana AB
    • Biacore (GE Healthcare)
    • Bioptix Inc.
    • Biorad Laboratories
    • Eppendorf AG
    • F.Hoffman La Roche
    • ForteBio
    • GWC Technologies
    • Molecular Devices LLC
    • PerkinElmer

第7章 市場機會與未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 66033

Market Overview

In recent years, label-free array systems have taken center stage as the research tool in many drug discovery processes. Label-free technologies are also used by manufacturers in context to patient samples, to produce biorelevant data that can result in effective drug development and precision medicine.

The global label-free array systems market is anticipated to witness a steady growth of approximately 6.2% CAGR during the forecast period, 2019-2024. As per the report, the global label-free array systems market was estimated to be worth USD 1245.11 million in 2018.

Modern medicine is moving toward precision or personalized medicine, to eliminate dosing redundancy in individuals. However, the biggest challenges in drug discovery and development are individual variability in drug effectiveness and a lack of translatability of pre-clinical results. Hence, companies are focusing on developing appropriate cellular models and readout systems to understand mechanisms and functional characterization on molecular and cellular levels. Moreover, next-gen label-free technologies, including mass spectrometers, biochips/microarrays, and others, have shown positive results in identifying clinical microorganisms. Companies are also developing micro plate-based optical biosensors that can be incorporated in the standard format microplates, to detect small molecules, cells, and proteins.

Scope of the Report

Biotechnology and pharmaceutical companies use label-free array systems in the drug discovery process. It works on the principle of refractive index, impedance-based assays, and optical interferometry, for identifying and validating new molecules as the possible drug candidates. The systems reduce the cost and time for drug identification and validation process.

As per the scope of this report, the global label-free array systems market is segmented by technology, application, end user, and geography.

Key Market Trends

The Surface Plasmon Resonance Technology Segment is Expected to the Exhibit the Fastest Growth During the Forecast Period

Based on the technology, the segmentation includes cellular dielectric spectroscopy, bio-layer interferometry, surface plasmon resonance, and other technologies. Among these, surface plasmon resonance technology is likely to experience significant growth in the global label-free array systems market.

North America Accounted for the Largest Share in the Global Market and is also the Fastest-growing Market

Region-wise, North America is expected to emerge as the leading region in the global label-free array systems market. The rise in chronic and life-threatening diseases is resulting in an increase in drug discovery programs in the United States. This is leading to increasing demand for label-free array systems in the region. The companies are also introducing label-free cell-based systems for early drug discovery. Meanwhile, certain issues, including a limit of detection and probability of the device, and the sensitivity of the device, are being optimized by manufacturers to offer better label-free array systems.

Competitive Landscape

The global label-free array systems market is dominated by a few major players, and the global label-free array systems market is expected to experience growth, owing to the rising collaboration and partnerships between pharmaceutical and biotechnology companies, for expediting various drug discovery/designing processes.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advantages over Labeled Detection Techniques
    • 4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies
    • 4.2.3 Technological Advancements in Label-free Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Instrumentation Costs
    • 4.3.2 Lack of Awareness
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Technology
    • 5.1.1 Surface Plasmon Resonance
    • 5.1.2 Bio Layer Interferometry
    • 5.1.3 Cellular Dielectric Spectroscopy
    • 5.1.4 Other Technologies
  • 5.2 Application
    • 5.2.1 Drug Discovery
    • 5.2.2 Protein Interface Analysis
    • 5.2.3 Antibody Characterization and Development
    • 5.2.4 Protein Complex and Cascade Analysis
    • 5.2.5 Other Applications
  • 5.3 End User
    • 5.3.1 Contract Research Organizations
    • 5.3.2 Agricultural Research Institutes
    • 5.3.3 R&D Labs
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Attana AB
    • 6.1.3 Biacore (GE Healthcare)
    • 6.1.4 Bioptix Inc.
    • 6.1.5 Biorad Laboratories
    • 6.1.6 Eppendorf AG
    • 6.1.7 F.Hoffman La Roche
    • 6.1.8 ForteBio
    • 6.1.9 GWC Technologies
    • 6.1.10 Molecular Devices LLC
    • 6.1.11 PerkinElmer

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top